Bulletin
Investor Alert

New York Markets After Hours

press release

Aug. 7, 2020, 1:00 a.m. EDT

ObsEva SA to present at the Wedbush PacGrow Healthcare Virtual Conference, August 11 - 12, 2020

Aug 07, 2020 (GLOBE NEWSWIRE via COMTEX) --

Geneva, Switzerland and Boston, MA - August 7, 2020 - ObsEva SA /zigman2/quotes/208216166/composite OBSV -4.80% , a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women's reproductive health, today announced that CEO Ernest Loumaye will present an update on the Company and its pipeline at the Wedbush PacGrow Virtual Healthcare Conference taking place August 11 - 12, 2020.

Mr. Loumaye's presentation will take place on Wednesday August 12, 2020 at 9:45 a.m. Eastern Time (ET). A live presentation link will be available under "Events Calendar" in the investors section of ObsEva's website at www.ObsEva.com

About ObsEva

ObsEva is a biopharmaceutical company developing and commercializing novel therapies to improve women's reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids, preterm labor, and improving ET outcomes following IVF. ObsEva is listed on the Nasdaq Global Select Market and is trading under the ticker symbol "OBSV" and on the SIX Swiss Exchange where it is trading under the ticker symbol "OBSN". For more information, please visit www.ObsEva.com .

For further information, please contact:

CEO Office contact
Shauna Dillon
Shauna.dillon@ obseva .ch
+41 22 552 1550

Investor Contact
Mario Corso
Vice President, Investor Relations
mario.corso@obseva.com

+1 857 972 9347 Office
+1 781 366 5726 Mobile

Attachment

COMTEX_369013397/2471/2020-08-07T01:00:18

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

(C) Copyright 2020 GlobeNewswire, Inc. All rights reserved.

/zigman2/quotes/208216166/composite
US : U.S.: Nasdaq
$ 2.48
-0.13 -4.80%
Volume: 566,491
Sept. 24, 2020 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$145.66 million
Rev. per Employee
N/A
loading...

Link to MarketWatch's Slice.